October 1, 2016 — To advance clinical care for its customers, Toshiba’s Celesteion PET/CT system delivers a more comfortable patient experience with the industry’s largest bore, widest field of view and time-of-flight imaging. The versatile system combines high-performance PET and CT for all radiation and oncology imaging needs, including tumor detection, treatment evaluation and CT simulation. 

The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors and investigators in the Prostate Testing for Cancer and Treatment (ProtecT) trial, which randomized care for 2,664 men. Findings from the trial were published in the New England Journal of Medicine.

Hitachi Aloka Medical America recently announced the support of its Arietta 70 and Arietta 60 ultrasound systems with iVu Imaging Corp.’s Sofia 3-D whole-breast imaging system. The Hitachi Arietta platform and its long linear transducer enable the Sofia system to automate the 3-D radial acquisition of an entire breast in nearly half the time of previous-generation ultrasound systems.

Agfa HealthCare has expanded its DX-D Retrofit line with the DX-D 60.  This versatile, vendor-neutral direct radiography (DR) detector easily fits into existing radiography rooms and provides DR workflow without the higher cost of room replacement. In addition to virtually instant image access, technologists do not have to rotate the 17x17 inch DX-D 60 for radiology exams that would otherwise require portrait and landscape detector rotations, thus greatly improving image acquisition speed and workflow.

New research suggests enhanced, culturally-competent communication with early-stage lung cancer patients can narrow racial gaps in curative treatment completion and increase treatment rates for all races. The study, part of a project supported by the National Cancer Institute, found that multiple, coordinated modalities of patient support essentially eliminated the inequity in curative treatment and improved completion of care for all patients.

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to new research. Women receiving IMRT reported significantly fewer bowel and bladder problems than those receiving conventional radiation treatment.

The Medicare Shared Savings Program (MSSP) has produced small but significant improvements in mammography utilization in its first three years, according to a new study published online in the journal Radiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now